Metabolomics as a promising tool for early osteoarthritis diagnosis

• Published in: Brazilian journal of medical and biological research 2017-01, Vol.50 (11), p.e6485-e6485
• Main Authors: de Sousa, E B, Dos Santos, Junior, G C, Duarte, M E L, Moura, Neto, V, Aguiar, D P
• Format: Article
• Language: English
• Subjects: Animals; BIOLOGY; Biomarkers - metabolism; Development and progression; Diagnosis; Diagnostic imaging; Early Diagnosis; Health aspects; Humans; Magnetic Resonance Spectroscopy - methods; Mass spectrometry; Mass Spectrometry - methods; MEDICINE, RESEARCH & EXPERIMENTAL; Metabolites; Metabolomics; Metabolomics - methods; Metabolomics - trends; NMR; Osteoarthritis; Osteoarthritis - diagnosis; Osteoarthritis - metabolism; Osteoarthritis - physiopathology; Reviews; Synovial Fluid; Synovial Fluid - metabolism
• ISSN: 0100-879X; 1414-431X; 1414-431X
• DOI: 10.1590/1414-431X20176485

Osteoarthritis (OA) is the main cause of disability worldwide, due to progressive articular cartilage loss and degeneration. According to recent research, OA is more than just a degenerative disease due to some metabolic components associated to its pathogenesis. However, no biomarker has been identified to detect this disease at early stages or to track its development. Metabolomics is an emerging field and has the potential to detect many metabolites in a single spectrum using high resolution nuclear magnetic resonance (NMR) techniques or mass spectrometry (MS). NMR is a reproducible and reliable non-destructive analytical method. On the other hand, MS has a lower detection limit and is more destructive, but it is more sensitive. NMR and MS are useful for biological fluids, such as urine, blood plasma, serum, or synovial fluid, and have been used for metabolic profiling in dogs, mice, sheep, and humans. Thus, many metabolites have been listed as possibly associated to OA pathogenesis. The goal of this review is to provide an overview of the studies in animal models and humans, regarding the use of metabolomics as a tool for early osteoarthritis diagnosis. The concept of osteoarthritis as a metabolic disease and the importance of detecting a biomarker for its early diagnosis are highlighted. Then, some studies in plasma and synovial tissues are shown, and finally the application of metabolomics in the evaluation of synovial fluid is described.